CoChat

Registering New Drugs for Low-Income Countries: The African Challenge

Open access
Moran, Mary, Strub-Wourgaft, Nathalie, Guzman, Javier, Boulet, Pascale, Wu, Lindsey, Pecoul, Bernard · 2011 · PLoS Medicine

The DOI matches its Crossref record; 4 of the 5 references it cites were found in a registry or an index.

Abstract

The Policy Forum allows health policy makers around the world to discuss challenges and opportunities for improving

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1000411

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Neglected disease drug registration timeline [7],[9],[11]–[19]. Additional source: correspondence with Novartis.
Figure 1 Neglected disease drug registration timeline [7],[9],[11]–[19]. Additional source: correspondence with Novartis.CC BY · PubMed Central
Figure 2 WHO prequalified drugs by disease [7].
Figure 2 WHO prequalified drugs by disease [7].CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 1

  1. 2008, Novartis receives FDA priority review for Coartem®, potentially the first artemisinin-based combination treatment (ACT) for malaria in the US [press release].

Cited by

See all 45

Metadata

Authors
Moran, M., Strub-Wourgaft, N., Guzman, J., Boulet, P., Wu, L., & Pecoul, B.
Affiliations
  • Policy Cures (AU)
  • Drugs for Neglected Diseases Initiative (CH)
Corresponding author
Moran, Mary
Venue
PLoS Medicine
Published
2011-02-01
Volume
8
Issue
2
Pages
e1000411
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
OpenAlex
W2073360669
Cited by
44
References
5
Citations by year
2026: 2 · 2025: 2 · 2023: 3 · 2022: 2 · 2021: 3 · 2020: 3 · 2019: 3 · 2018: 4 · 2017: 3 · 2016: 2 · 2015: 1 · 2014: 3 · 2013: 3 · 2012: 6
FWCI
12.98
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • PLoS Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Wellcome Trust
  • National Institute for Health and Care Research
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pharmaceutical Quality and Counterfeiting
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Healthcare Systems and Reforms
Keywords
drug registration, new drugs, low-income countries, Africa, drug regulation, access to medicines, health policy
MeSH terms
Africa, Developing Countries, Humans, Poverty, Registries, Drug Approval, Government Regulation, Neglected Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Registering New Drugs for Low-Income Countries: The African Challenge. https://app.cochat.ai/papers/10.1371/journal.pmed.1000411
The paper
Moran, M., Strub-Wourgaft, N., Guzman, J., Boulet, P., Wu, L., & Pecoul, B. (2011). Registering New Drugs for Low-Income Countries: The African Challenge. PLoS Medicine. https://doi.org/10.1371/journal.pmed.1000411

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.